BNP Paribas Exane Has Lowered Expectations for GE HealthCare Technologies (NASDAQ:GEHC) Stock Price

GE HealthCare Technologies (NASDAQ:GEHC) had its price target reduced by analysts at BNP Paribas Exane from $95.00 to $88.00 in a note issued to investors on Friday,MarketScreener reports. BNP Paribas Exane’s price target would suggest a potential upside of 44.26% from the company’s current price.

GEHC has been the topic of several other research reports. Barclays reduced their target price on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a research note on Thursday. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, March 21st. Bank of America raised their target price on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research note on Monday, January 5th. Piper Sandler reduced their target price on shares of GE HealthCare Technologies from $96.00 to $88.00 and set an “overweight” rating on the stock in a research note on Friday, April 17th. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $85.00 target price on shares of GE HealthCare Technologies in a research note on Thursday. Eight equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $82.00.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock traded down $0.03 during mid-day trading on Friday, hitting $61.00. 7,797,771 shares of the company were exchanged, compared to its average volume of 4,011,384. GE HealthCare Technologies has a 1-year low of $58.75 and a 1-year high of $89.77. The company has a market capitalization of $27.75 billion, a PE ratio of 14.59, a price-to-earnings-growth ratio of 1.37 and a beta of 0.75. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The business has a fifty day moving average of $73.28 and a 200 day moving average of $77.60.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. During the same quarter last year, the business posted $1.01 earnings per share. The business’s quarterly revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, sell-side analysts expect that GE HealthCare Technologies will post 4.88 earnings per share for the current year.

Insider Buying and Selling at GE HealthCare Technologies

In related news, CEO Peter J. Arduini acquired 4,169 shares of the business’s stock in a transaction dated Thursday, April 30th. The stock was bought at an average price of $59.92 per share, with a total value of $249,806.48. Following the acquisition, the chief executive officer owned 259,424 shares in the company, valued at $15,544,686.08. This represents a 1.63% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Frank R. Jimenez acquired 1,750 shares of the business’s stock in a transaction dated Thursday, April 30th. The stock was bought at an average cost of $60.45 per share, with a total value of $105,787.50. Following the acquisition, the insider owned 93,932 shares in the company, valued at $5,678,189.40. The trade was a 1.90% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last quarter, insiders have bought 9,229 shares of company stock worth $556,180. Corporate insiders own 0.36% of the company’s stock.

Institutional Investors Weigh In On GE HealthCare Technologies

A number of large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its stake in GE HealthCare Technologies by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock valued at $4,287,658,000 after acquiring an additional 267,058 shares during the period. Auto Owners Insurance Co raised its stake in GE HealthCare Technologies by 9,525.4% in the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after acquiring an additional 33,629,559 shares during the period. Dodge & Cox increased its position in GE HealthCare Technologies by 13.4% during the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock worth $2,559,945,000 after buying an additional 3,693,918 shares during the period. Capital Research Global Investors increased its position in GE HealthCare Technologies by 1.6% during the 4th quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock worth $2,080,248,000 after buying an additional 389,796 shares during the period. Finally, State Street Corp increased its position in GE HealthCare Technologies by 2.0% during the 4th quarter. State Street Corp now owns 20,049,677 shares of the company’s stock worth $1,644,475,000 after buying an additional 401,932 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.